Literature DB >> 15840118

Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumour necrosis factor-alpha.

A Tsianakas1, P H Hoeger.   

Abstract

Febrile ulceronecrotic Mucha-Habermann disease (FUMHD) represents a fulminant and potentially lethal variant of pityriasis lichenoides. Only 24 cases have been described so far. We report a 9-year-old boy who initially presented with classical pityriasis lichenoides et varioliformis acuta (PLEVA) following a mild enteritis. Three weeks later, his skin lesions started to ulcerate progressively, involving > 90% of his body surface, accompanied by high fever, normal C-reactive protein, but highly elevated serum levels of tumour necrosis factor (TNF)-alpha. Methotrexate 10 mg m(-2) weekly was required to halt disease progression, while oral steroids (initial dose 2.8 mg kg(-1) daily) alone proved insufficient. Sequential histology revealed progressively dense perivascular and intramural lymphocytic inflammation as well as keratinocyte necrosis. Our case demonstrates the clinical and histological continuum between 'classical' PLEVA and FUMHD and points to the potentially pathogenic significance of TNF-alpha. We hypothesize that in future cases, treatment with TNF-alpha antagonists might represent a reasonable alternative to high-dose immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840118     DOI: 10.1111/j.1365-2133.2005.06485.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  [Febrile ulceronecrotic Mucha-Habermann syndrome].

Authors:  G Kukova; P A Gerber; N J Neumann; D Bruch-Gerharz; B Homey
Journal:  Hautarzt       Date:  2007-10       Impact factor: 0.751

2.  Febrile ulceronecrotic Mucha-Habermann disease.

Authors:  F-X Lejuste; C Michaux; C Lehners; N Calteux
Journal:  BMJ Case Rep       Date:  2013-10-14

3.  CASE REPORT Febrile Ulceronecrotic Mucha-Habermann Disease.

Authors:  Patrick S Harenberg; Manuel Hrabowski; Henning Ryssel; Emre Gazyakan; Günter Germann; Holger Engel; Matthias A Reichenberger
Journal:  Eplasty       Date:  2010-07-16

4.  Febrile ulceronecrotic Mucha-Habermann disease following suspected hemorrhagic chickenpox infection in a 20-month-old boy.

Authors:  H N Lode; P Döring; P Lauenstein; P Hoeger; F Dombrowski; R Bruns
Journal:  Infection       Date:  2015-01-28       Impact factor: 7.455

5.  Methotrexate Treatment in Children with Febrile Ulceronecrotic Mucha-Habermann Disease: Case Report and Literature Review.

Authors:  Isil Bulur; Hilal Kaya Erdoğan; Zeynep Nurhan Saracoglu; Deniz Arık
Journal:  Case Rep Dermatol Med       Date:  2015-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.